Clinical Trial Update: Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD [NA]

View source ↗

Summary

The clinical trial evaluating omega-3 polyunsaturated fatty acids in youth with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: China Medical University Hospital | Conditions: Attention Deficit Hyperactivity Disorder, ADHD | NA | Status: COMPLETED